ArticleTargeted oncology2023

Prognostic Significance of the Severity of Immune-Related Adverse Events in Advanced Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Real-World Data Analysis.

Su Jeong Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.